Foresite Capital Management IV, LLC - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foresite Capital Management IV, LLC ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,235,033
-33.9%
2,808,0340.0%10.68%
-25.4%
Q2 2023$29,119,313
+28.2%
2,808,0340.0%14.32%
+21.5%
Q1 2023$22,716,995
-48.6%
2,808,0340.0%11.79%
-37.6%
Q4 2022$44,226,536
+0.1%
2,808,0340.0%18.89%
+32.9%
Q3 2022$44,198,000
+12.8%
2,808,0340.0%14.21%
+34.7%
Q2 2022$39,200,000
-21.6%
2,808,034
-3.1%
10.56%
-24.5%
Q1 2022$49,979,000
+1.1%
2,899,034
-14.7%
13.98%
+37.5%
Q4 2021$49,422,000
-19.2%
3,399,0340.0%10.17%
+12.9%
Q3 2021$61,183,000
+2.5%
3,399,0340.0%9.01%
+11.7%
Q2 2021$59,687,000
-30.3%
3,399,0340.0%8.07%
-21.4%
Q1 2021$85,656,000
+1291.6%
3,399,034
+257.3%
10.26%
+1433.6%
Q4 2020$6,155,000
+1554.6%
951,384
+556.7%
0.67%
+696.4%
Q3 2020$372,000
-93.3%
144,874
-80.6%
0.08%
-96.7%
Q4 2018$5,529,000
-28.1%
748,132
+41.3%
2.54%
+0.7%
Q3 2018$7,689,000
-27.3%
529,5510.0%2.52%
-30.1%
Q2 2018$10,575,000
+40.5%
529,551
+23.3%
3.60%
+15.5%
Q1 2018$7,526,000
+21.1%
429,551
+70.5%
3.12%
-28.4%
Q4 2017$6,213,000251,9364.36%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders